You are here

Article info

Article menu
Download PDFPDF
PostScript
PostScript
Elevated interferon-gamma levels during pregnancy are associated with adverse maternofetal outcomes in IBD

Authors

  1. Correspondence to Dr Cynthia H Seow, Department of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada; cseow{at}ucalgary.ca
View Full Text

Citation

Jijon H, Ueno A, Sharifi N, et al
Elevated interferon-gamma levels during pregnancy are associated with adverse maternofetal outcomes in IBD
Gut 2020;69:1895-1897.

Publication history

  • Received August 15, 2019
  • Revised October 29, 2019
  • Accepted October 30, 2019
  • First published November 13, 2019.
Online issue publication 
December 06, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.